Comment on Rosenstock et al. Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial. Diabetes Care 2020;43:2509–2518

Simple item page
dc.contributor.authorMarathe, C.S.
dc.contributor.authorJones, K.L.
dc.contributor.authorRayner, C.K.
dc.contributor.authorWu, T.
dc.contributor.authorHorowitz, M.
dc.date.issued2021
dc.descriptionComments and Responses
dc.description.abstractAbstract unavailable
dc.description.statementofresponsibilityChinmay S. Marathe, Karen L. Jones, Christopher K. Rayner, Tongzhi Wu, and Michael Horowitz
dc.identifier.citationDiabetes Care, 2021; 44(11):e194-e195
dc.identifier.doi10.2337/dc20-2987
dc.identifier.issn0149-5992
dc.identifier.issn1935-5548
dc.identifier.orcidJones, K.L. [0000-0002-1155-5816]
dc.identifier.orcidRayner, C.K. [0000-0002-5527-256X]
dc.identifier.orcidWu, T. [0000-0003-1656-9210]
dc.identifier.orcidHorowitz, M. [0000-0002-0942-0306]
dc.identifier.urihttps://hdl.handle.net/2440/145901
dc.language.isoen
dc.publisherAmerican Diabetes Association
dc.rights© 2021 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license.
dc.source.urihttps://doi.org/10.2337/dc20-2987
dc.subjectComments; Comments and Responses; Glucagon-Like Peptide 1 Receptor Agonist; Albiglutide; Prandial Insulin; Type 2 Diabetes
dc.subject.meshHumans
dc.subject.meshDiabetes Mellitus, Type 2
dc.subject.meshInsulin
dc.subject.meshHypoglycemic Agents
dc.subject.meshGlucagon-Like Peptide 1
dc.subject.meshGlycemic Control
dc.titleComment on Rosenstock et al. Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial. Diabetes Care 2020;43:2509–2518
dc.typeJournal article
pubs.publication-statusPublished online

Files

Collections

Research Outputs